The Novel Omega-6 Fatty Acid Docosapentaenoic Acid Positively Modulates Brain Innate Immune Response for Resolving Neuroinflammation at Early and Late Stages of Humanized APOE-Based Alzheimer's Disease Models
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Neuroinflammation plays a crucial role in the development and progression of Alzheimer’s disease (AD), in which activated microglia are found to be associated with neurodegeneration. However, there is limited evidence showing how neuroinflammation and activated microglia are directly linked to neurodegeneration in vivo. Besides, there are currently no effective anti-inflammatory drugs for AD. In this study, we report on an effective anti-inflammatory lipid, linoleic acid (LA) metabolite docosapentaenoic acid (DPAn-6) treatment of aged humanized EFAD mice with advanced AD pathology. We also report the associations of neuroinflammatory and/or activated microglial markers with neurodegeneration in vivo. First, we found that dietary LA reduced proinflammatory cytokines of IL1-, IL-6, as well as mRNA expression of COX2 towards resolving neuroinflammation with an increase of IL-10 in adult AD models E3FAD and E4FAD mice. Brain fatty acid assays showed a five to six-fold increase in DPAn-6 by dietary LA, especially more in E4FAD mice, when compared to standard diet. Thus, we tested DPAn-6 in aged E4FAD mice. After DPAn-6 was administered to the E4FAD mice by oral gavage for three weeks, we found that DPAn-6 reduced microgliosis and mRNA expressions of inflammatory, microglial, and caspase markers. Further, DPAn-6 increased mRNA expressions of ADCYAP1, VGF, and neuronal pentraxin 2 in parallel, all of which were inversely correlated with inflammatory and microglial markers. Finally, both LA and DPAn-6 directly reduced mRNA expression of COX2 in amyloid-beta42 oligomer-challenged BV2 microglial cells. Together, these data indicated that DPAn-6 modulated neuroinflammatory responses towards resolution and improvement of neurodegeneration in the late stages of AD models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329 · cited 1×
“Although numerous studies have demonstrated that activated microglia respond to phagocytosis of Aβ (74), however, after a prolonged period of activation, these activated microglia may decrease or lose their Aβ phagocytic capacity (75, 76).”
BackgroundAstrocytes are active players in cerebral innate immunity
Farina, C., Aloisi, F., & Meinl, E. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.005 · Cited by 1,304 · cited 1×
“Attenuation of Microgliosis With DPAn-6 in Aged E4FAD Mice Since microglia are primary CNS resident immune cells (46, 47) that consistently respond to Aβ deposits and/or neurodegeneration in AD to cause neuroinflammation and microgliosis (48), we further evaluated the impact of DPAn6 on microglia.”
BackgroundRole of Pro-Inflammatory Cytokines Released from Microglia in Neurodegenerative Diseases
Smith, J. A., Das, A., Ray, S. K., & Banik, N. L. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.10.004 · Cited by 1,165
Risk of Alzheimer's disease and duration of NSAID use
Stewart, W. F., Kawas, C., Corrada, M., & Metter, E. J. (1997) · Neurology · doi:10.1212/wnl.48.3.626 · Cited by 1,132 · cited 1×
“In an early longitudinal study of aging which included 1,686 participants, a 50% reduction of AD was associated with consistent NSAID consumption (10).”
BackgroundApolipoprotein E polymorphism and Alzheimer's disease
Poirier, J., Bertrand, P., Poirier, J., Kogan, S., Gauthier, S., Poirier, J., Gauthier, S., Davignon, J., Bouthillier, D., & Davignon, J. (1993) · The Lancet · doi:10.1016/0140-6736(93)91705-q · Cited by 1,108
Johnson, E. C. B., Dammer, E. B., Duong, D. M., Ping, L., Zhou, M., Yin, L., Higginbotham, L. A., Guajardo, A., White, B., Troncoso, J. C., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0815-6 · Cited by 1,001
Freund-Levi, Y., Eriksdotter-Jönhagen, M., Cederholm, T., Basun, H., Faxén-Irving, G., Garlind, A., Vedin, I., Vessby, B., Wahlund, L.-O., & Palmblad, J. (2006) · Archives of Neurology · doi:10.1001/archneur.63.10.1402 · Cited by 751
Jay, T. R., Miller, C. M., Cheng, P. J., Graham, L. C., Bemiller, S., Broihier, M. L., Xu, G., Margevicius, D., Karlo, J. C., Sousa, G. L., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142322 · Cited by 682 · cited 1×
“In support of this concept, TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology at later stages in ADmousemodels (73).”
BackgroundTREM2 sustains microglial expansion during aging and response to demyelination
Poliani, P. L., Wang, Y., Fontana, E., Robinette, M. L., Yamanishi, Y., Gilfillan, S., & Colonna, M. (2015) · Journal of Clinical Investigation · doi:10.1172/jci77983 · Cited by 525 · cited 1×
“TREM2 is a key player in the sustained-microglial expansion during aging (72) although its function is not yet fully understood.”
BackgroundCribbs, D. H., Berchtold, N. C., Perreau, V., Coleman, P. D., Rogers, J., Tenner, A. J., & Cotman, C. W. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-179 · Cited by 499 · cited 1×
“DPAn-6 reduced mRNA expressions of IL1RL2, IL6RA, IL6ST, TNFR2, TRAIL, and IL10Rß (Figure 2), which are all significantly upregulated in AD brain (36, 37, 40, 42).”
Background
Research works printed but not linked: 50
- Guerreiro, 2013, TREM2 variants in Alzheimer's disease, N Engl J Med., 368, 117, 10.1056/NEJMoa1211851 · DOI · Paper page
- Jonsson, 2013, Variant of TREM2 associated with the risk of Alzheimer's disease, N Engl J Med., 368, 107, 10.1056/NEJMoa1211103 · DOI · Paper page
- Malik, 2013, CD33 Alzheimer's risk-altering polymorphism, CD33 expression, and exon 2 splicing, J Neurosci., 33, 13320, 10.1523/JNEUROSCI.1224-13.2013 · DOI · Paper page
- Keren-Shaul, 2017, A unique microglia type associated with restricting development of Alzheimer's Disease, Cell., 169, 1276, 10.1016/j.cell.2017.05.018 · DOI · Paper page
- Migliore, 2009, Genetics, environmental factors and the emerging role of epigenetics in neurodegenerative diseases, Mutat Res., 667, 82, 10.1016/j.mrfmmm.2008.10.011 · DOI · Paper page
- Lim, 2000, Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer's disease, J Neurosci., 20, 5709, 10.1523/JNEUROSCI.20-15-05709.2000 · DOI · Paper page
- Zarghi, 2011, Selective COX-2 inhibitors: a review of their structure-activity relationships, Iran J Pharm Res., 10, 655
- Miguel-Alvarez, 2015, Non-steroidal anti-inflammatory drugs as a treatment for Alzheimer's disease: a systematic review and meta-analysis of treatment effect, Drugs Aging., 32, 139, 10.1007/s40266-015-0239-z · DOI · Paper page
- Miyata, 2015, Role of omega-3 fatty acids and their metabolites in asthma and allergic diseases, Allergol Int., 64, 27, 10.1016/j.alit.2014.08.003 · DOI · Paper page
- Schwanke, 2016, EPA- and DHA-derived resolvins' actions in inflammatory bowel disease, Eur J Pharmacol., 785, 156, 10.1016/j.ejphar.2015.08.050 · DOI
- Navarro-Xavier, 2016, Protective effect of soybean oil- or fish oil-rich diets on allergic airway inflammation, J Inflamm Res., 9, 79, 10.2147/JIR.S102221 · DOI
- Hamanaka, 2000, Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice, Human Mol Gen., 9, 353, 10.1093/hmg/9.3.353 · DOI · Paper page
- Lim, 2005, A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model, J Neurosci., 25, 3032, 10.1523/JNEUROSCI.4225-04.2005 · DOI · Paper page
- Moriguchi, 2000, Behavioral deficits associated with dietary induction of decreased brain docosahexaenoic acid concentration, J Neurochem., 75, 2563, 10.1046/j.1471-4159.2000.0752563.x · DOI · Paper page
- Calon, 2004, Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model, Neuron., 43, 633, 10.1016/j.neuron.2004.08.013 · DOI · Paper page
- Yang, 1998, Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease, Am J Pathol., 152, 379
- Dobin, 2013, STAR: ultrafast universal RNA-seq aligner, Bioinformatics., 29, 15, 10.1093/bioinformatics/bts635 · DOI · Paper page
- Law, 2014, voom: Precision weights unlock linear model analysis tools for RNA-seq read counts, Genome Biol., 15, R29, 10.1186/gb-2014-15-2-r29 · DOI · Paper page
- Law, 2016, RNA-seq analysis is easy as 1-2-3 with limma, Glimma and edgeR, F1000Res., 5, 2, 10.12688/f1000research.9005.2 · DOI · Paper page
- Zhang, 2019, Novel data transformations for RNA-seq differential expression analysis, Sci Rep., 9, 4820, 10.1038/s41598-019-41315-w · DOI
- Costa-Silva, 2017, RNA-Seq differential expression analysis: An extended review and a software tool, PLoS ONE., 12, e0190152, 10.1371/journal.pone.0190152 · DOI · Paper page
- Saini, 2018, Omega-3 and omega-6 polyunsaturated fatty acids: dietary sources, metabolism, and significance - A review, Life Sci., 203, 255, 10.1016/j.lfs.2018.04.049 · DOI · Paper page
- Innes, 2018, The differential effects of eicosapentaenoic acid and docosahexaenoic acid on cardiometabolic risk factors: a systematic review, Int J Mol Sci., 19, 32, 10.3390/ijms19020532 · DOI · Paper page
- Xiong, 2014, Alzheimer's disease: evidence for the expression of interleukin-33 and its receptor ST2 in the brain, J Alzheimers Dis., 40, 297, 10.3233/JAD-132081 · DOI · Paper page
- Hampel, 2005, Pattern of interleukin-6 receptor complex immunoreactivity between cortical regions of rapid autopsy normal and Alzheimer's disease brain, Eur Arch Psychiatry Clin Neurosci., 255, 269, 10.1007/s00406-004-0558-2 · DOI
- Buchhave, 2010, Soluble TNF receptors are associated with Abeta metabolism and conversion to dementia in subjects with mild cognitive impairment, Neurobiol Aging., 31, 1877, 10.1016/j.neurobiolaging.2008.10.012 · DOI
- Li, 2004, Tumor necrosis factor death receptor signaling cascade is required for amyloid-beta protein-induced neuron death, J Neurosci., 24, 1760, 10.1523/JNEUROSCI.4580-03.2004 · DOI · Paper page
- Shouval, 2014, Interleukin-10 receptor signaling in innate immune cells regulates mucosal immune tolerance and anti-inflammatory macrophage function, Immunity., 40, 706, 10.1016/j.immuni.2014.03.011 · DOI · Paper page
- Sudduth, 2013, Neuroinflammatory phenotype in early Alzheimer's disease, Neurobiol Aging., 34, 1051, 10.1016/j.neurobiolaging.2012.09.012 · DOI · Paper page
- D'Anna, 2017, Serum interleukin-10 levels correlate with cerebrospinal fluid amyloid beta deposition in alzheimer disease patients, Neurodegener Dis., 17, 227, 10.1159/000474940 · DOI
- Wang, 2003, Preliminary studies on Alzheimer's disease using cDNA microarrays, Mech Ageing Dev., 124, 115, 10.1016/S0047-6374(02)00188-4 · DOI
- Nauroth, 2010, Docosahexaenoic acid (DHA) and docosapentaenoic acid (DPAn-6) algal oils reduce inflammatory mediators in human peripheral mononuclear cells in vitro and paw edema in vivo, Lipids, 45, 375, 10.1007/s11745-010-3406-3 · DOI · Paper page
- Glenn, 1989, Further studies on the identification of microglia in mixed brain cell cultures, Brain Res Bull., 22, 1049, 10.1016/0361-9230(89)90018-X · DOI
- Glenn, 1992, Characterisation of ramified microglial cells: detailed morphology, morphological plasticity and proliferative capability, J Anat., 1992, 109
- Kempuraj, 2016, Neuroinflammation induces neurodegeneration, J Neurol Neurosurg Spine., 1, 1003
- Cohen, 1997, Caspases: the executioners of apoptosis, Biochem J., 326, 1, 10.1042/bj3260001 · DOI · Paper page
- Graham, 2011, Caspase-6 and neurodegeneration, Trends Neurosci., 34, 646, 10.1016/j.tins.2011.09.001 · DOI
- Han, 2014, Pituitary adenylate cyclase-activating polypeptide is reduced in Alzheimer disease, Neurology., 82, 1724, 10.1212/WNL.0000000000000417 · DOI · Paper page
- Alder, 2003, Brain-derived neurotrophic factor-induced gene expression reveals novel actions of VGF in hippocampal synaptic plasticity, J Neurosci., 23, 10800, 10.1523/JNEUROSCI.23-34-10800.2003 · DOI · Paper page
- Carrette, 2003, A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease, Proteomics., 3, 1486, 10.1002/pmic.200300470 · DOI · Paper page
- Selle, 2005, Identification of novel biomarker candidates by differential peptidomics analysis of cerebrospinal fluid in Alzheimer's disease, Comb Chem High Throughput Screen., 8, 801, 10.2174/138620705774962391 · DOI
- Antonell, 2013, A preliminary study of the whole-genome expression profile of sporadic and monogenic early-onset Alzheimer's disease, Neurobiol Aging., 34, 1772, 10.1016/j.neurobiolaging.2012.12.026 · DOI
- Jahn, 2011, Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers, PLoS ONE., 6, e26540, 10.1371/journal.pone.0026540 · DOI · Paper page
- Hendrickson, 2015, High resolution discovery proteomics reveals candidate disease progression markers of alzheimer's disease in human cerebrospinal fluid, PLoS ONE., 10, e0135365, 10.1371/journal.pone.0135365 · DOI · Paper page
- Fritsche, 2008, Too much linoleic acid promotes inflammation-doesn't it?, Prostagl Leukotri Essent Fatty Acids., 79, 173, 10.1016/j.plefa.2008.09.019 · DOI · Paper page
- Kramer, 2002, Methotrexate pneumonitis after initiation of infliximab therapy for rheumatoid arthritis, Arthr Rheum., 47, 670, 10.1002/art.10803 · DOI
- Chang, 2016, Bipolar disorder moderates associations between linoleic acid and markers of inflammation, J Psychiatr Res., 85, 29, 10.1016/j.jpsychires.2016.10.021 · DOI
- Calder, 2002, Dietary modification of inflammation with lipids, Proc Nutr Soc., 61, 345, 10.1079/PNS2002166 · DOI · Paper page
- Cacabelos, 1994, Brain interleukin-1 beta in Alzheimer's disease and vascular dementia, Methods Find Exp Clin Pharmacol., 16, 141
- Bolmont, 2008, Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance, J Neurosci., 28, 4283, 10.1523/JNEUROSCI.4814-07.2008 · DOI · Paper page
Cited by
Dihydroxy‐Metabolites of Dihomo‐γ‐linolenic acid drive ferroptosis‐mediated neurodegeneration
Sarparast, M., Pourmand, E., Hinman, J., Vonarx, D., Reason, T., Zhang, F., Paithankar, S., Chen, B., Borhan, B., Watts, J. L., et al. (2023) · ACS Central Science · doi:10.1021/acscentsci.3c00052 · Cited by 33
Kan, Y., Wang, H., Lin, H., Li, Y., Pei, S., Cui, Y., Xie, K., Chen, H., & Yu, Y. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70003 · Cited by 8
Exploring the Prognosis-Related Genetic Variation in Gastric Cancer Based on mGWAS
Zhang, Y., Lyu, Y., Chen, L., Cao, K., Chen, J., He, C., Lyu, X., Jiang, Y., Xiang, J., Liu, B., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242015259 · Cited by 5
Metadata
- Authors
- Ma, Q.-L., Zhu, C., Morselli, M., Su, T., Pelligrini, M., Lu, Z., Jones, M., Denver, P., Castro, D., Gu, X., Relampagos, F., Caoili, K., Teter, B., Frautschy, S. A., & Cole, G. M.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-10-16
- Volume
- 11
- Pages
- 558036-558036
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3093096604
- Cited by
- 48
- References
- 27
- FWCI
- 1.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Novel Omega-6 Fatty Acid Docosapentaenoic Acid Positively Modulates Brain Innate Immune Response for Resolving Neuroinflammation at Early and Late Stages of Humanized APOE-Based Alzheimer's Disease Models. https://app.cochat.ai/papers/10.3389/fimmu.2020.558036
- The paper
- Ma, Q.-L., Zhu, C., Morselli, M., Su, T., Pelligrini, M., Lu, Z., Jones, M., Denver, P., Castro, D., Gu, X., Relampagos, F., Caoili, K., Teter, B., Frautschy, S. A., & Cole, G. M. (2020). The Novel Omega-6 Fatty Acid Docosapentaenoic Acid Positively Modulates Brain Innate Immune Response for Resolving Neuroinflammation at Early and Late Stages of Humanized APOE-Based Alzheimer's Disease Models. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2020.558036
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.